Insurance Coverage: Many major insurance plans no longer cover Invokana. Learn More
Tori Marsh - August 16, 2018
Have you ever gone to the pharmacy only to realize that you’re on the hook for a high copay or your insurance just won’t cover your medication at all. You’re not alone. Luckily, many drug manufacturers offer savings through copay cards, also known as manufacturer coupons. These programs are typically for brand-name drugs, and can lower the price of your medication to as little as $0.
GoodRx currently has information on over 680 active copay cards for hundreds of prescription medications. See More
Roni Shye - August 10, 2018
You’re ready to pick up your prescription at the pharmacy. But how expensive will it be? And is there anything you can do to save money? Let’s discuss how to use pharmacy discount coupons and manufacturer savings cards to help you save on the medications you need.
First, what’s the difference between pharmacy discount coupons and manufacturer savings cards?
Pharmacy discount coupons
Tori Marsh - August 02, 2018
Well-known for treating type 2 diabetes, Jardiance can also reduce the risk of a cardiovascular event by 38%—but it’s expensive. A 30-day supply costs well over $500, and many insurance plans won’t cover it. Luckily, there are ways for you to save as much as 100% off the cash price.
How much does Jardiance cost?
As of August 2018, the cash price for Jardiance is over $500 for 30 tablets. GoodRx discounts can help reduce this price a bit—to around $450—but that’s still way too much for most people. See More
Tori Marsh - June 27, 2018
Let’s start with the bad news. Invokana, a tablet taken to treat type 2 diabetes, is really expensive. A 30-day supply of Invokana can cost around $550, and we may have to wait another six years to see a generic. But there is good news — there are ways to save.
Here’s all the information you need to make your Invokana prescription affordable.
How popular is Invokana?
Approved in 2013, Invokana is one of the most popular SGLT2 inhibitors, a class of drugs that is used to treat diabetes type 2 by blocking the kidneys from reabsorbing glucose so any excess is excreted from the body. See More
Tori Marsh - June 14, 2018
Brand drugs are expensive — this we already know, and prices seem to only be increasing. Of the 100 most-prescribed brand-name medications, those for diabetes, rheumatoid arthritis, and Crohn’s disease tend to be the most expensive. All of the drugs on this list are brand-only medications, meaning that there are no affordable generic alternatives available.
Additionally, it can be difficult for people to receive adequate insurance coverage for many of these drugs as they may be placed in more expensive, higher-tier formularies or have some other coverage restrictions. See More
Roni Shye - January 16, 2018
If you’ve ever been afraid to show up at your doctor’s office because you’ve been “bad” then this post is for YOU! You may think your doctor is “pushing medications on you” especially if you aren’t experiencing any symptoms of the condition they are treating you for. However, their reasoning is not without sound medical and professional judgment.
One of the many reasons you might receive a lecture about the importance of taking your medications is due to the progressive nature of many diseases if not properly treated. See More
Roni Shye - June 21, 2017
This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with canagliflozin than in patients who were given a placebo sugar pill. See More
Roni Shye - July 06, 2016
According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More
Roni Shye - June 08, 2016
The FDA has issued a safety alert for medications containing canagliflozin, a newer drug used to treat type 2 diabetes.
Do diabetics already have an increased risk of leg and foot amputations?
Yes. Diabetics have a higher risk of leg and foot amputations compared to a person who does not have diabetes. See More
Elizabeth Davis - August 12, 2015
It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.
Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More